Document Detail


Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells.
MedLine Citation:
PMID:  11429695     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
All eukaryotic cells manifest cell cycle delay after exposure to DNA damaging agents. It has been proposed that such cell cycle checkpoints may allow DNA repair but direct evidence of such activity during the radiation-induced G2 delay has been lacking. We report here that cells arrested in G2 by radiation (2-3 Gy) and etoposide incorporate bromodeoxyuridine (BrdU) at discrete foci in the nucleus. We detected G2 cells with CENP-F, a nuclear protein maximally expressed in G2. Caffeine and okadaic acid, both established radiosensitizers, inhibit the incorporation of BrdU in G2 cells. Radioresistant HT29 and OVCAR cells demonstrate BrdU foci formation more frequently during the G2 delay when compared to the more radiosensitive A2780 cell line. The repair foci formed during G2 may be followed through mitosis and observed in daughter cells in G1. Taken together, these observations are consistent with the detection of DNA repair activity during the radiation-induced G2 delay after relatively low doses of radiation.
Authors:
G D Kao; W G McKenna; T J Yen
Related Documents :
3427605 - Variability of ecdysteroid-induced cell cycle alterations in drosophila kc sublines.
3224365 - Cytostatic and cytotoxic effects of pannon (p-30 protein), a novel anticancer agent.
743595 - The cell cycle of an established cell line of the mosquito aedes aegypti.
8060335 - Increased activation of 2',3'-dideoxycytidine by acivicin.
7867085 - The role of peritoneal stromal cells in the survival of sigm+ peritoneal b lymphocyte p...
22682075 - Customizing cell signaling using engineered genetic logic circuits.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Oncogene     Volume:  20     ISSN:  0950-9232     ISO Abbreviation:  Oncogene     Publication Date:  2001 Jun 
Date Detail:
Created Date:  2001-06-28     Completed Date:  2001-07-19     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  England    
Other Details:
Languages:  eng     Pagination:  3486-96     Citation Subset:  IM    
Affiliation:
Hospital of the University of Pennsylvania, Department of Radiation Oncology, 2 Donner, 3400 Spruce Street, Philadelphia, Pennsylvania, PA 19104, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bromodeoxyuridine
Cell Cycle / drug effects,  genetics*,  radiation effects
Centromere / genetics
Chromosomal Proteins, Non-Histone / genetics
DNA Damage*
DNA Repair*
DNA, Neoplasm / drug effects,  genetics*,  radiation effects
Etoposide / toxicity
Female
Flow Cytometry
G2 Phase
Gamma Rays*
Hela Cells
Humans
Kinetics
Microfilament Proteins
Ovarian Neoplasms
Radiation Tolerance
Tumor Cells, Cultured
Grant Support
ID/Acronym/Agency:
P01 CA06927/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Chromosomal Proteins, Non-Histone; 0/DNA, Neoplasm; 0/Microfilament Proteins; 0/centromere protein F; 33419-42-0/Etoposide; 59-14-3/Bromodeoxyuridine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein.
Next Document:  Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with ...